Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jui‐Hua Tsai
Observed names:
J.-H. Tsai,
Jui-Hua Tsai
Observed institutions:
Johns Hopkins University,
Pharmerit (United States)
ORCID:
0000-0001-7046-9216
Observed ORCID:
0000-0001-7046-9216
OpenAlex ID:
A5015111046
Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
2020
·
Sandy Srinivas
, Ateesha F. Mohamed
, et al.
·
Cancer Medicine
·
34
How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event
2018
·
John F. P. Bridges
, Jui-Hua Tsai
, et al.
·
Patient
·
22
Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop
2019
·
Heather L. Benz
, Ting-Hsuan Lee
, et al.
·
Patient
·
21
Patient Preferences for Benefits, Risks, and Administration Route of Hypomethylating Agents in Myelodysplastic Syndromes
2022
·
Amer M. Zeidan
, Jui-Hua Tsai
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
19
Understanding what matters to metastatic castration‐resistant prostate cancer ( mCRPC ) patients when considering treatment options: A US patient preference survey
2022
·
Daniel J. George
, Ateesha F. Mohamed
, et al.
·
Cancer Medicine
·
13
Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice Experiment
2021
·
Jui-Hua Tsai
, Norah L. Crossnohere
, et al.
·
MDM Policy & Practice
·
13
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung Disease
2024
·
Kelly P. McCarrier
, Mariam Hassan
, et al.
·
Advances in Therapy
·
8
PDF
Patient and caregiver benefit-risk preferences for non-metastatic castration-resistant prostate cancer treatment (nmCRPC).
2019
·
Sandy Srinivas
, Ateesha F. Mohamed
, et al.
·
Journal of Clinical Oncology
·
5
Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
2024
·
Salini Mohanty
, Jui-Hua Tsai
, et al.
·
Human Vaccines & Immunotherapeutics
·
4
Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States
2024
·
Salini Mohanty
, Jui-Hua Tsai
, et al.
·
Expert Review of Vaccines
·
3
Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States
2024
·
Salini Mohanty
, Jui-Hua Tsai
, et al.
·
Expert Review of Vaccines
·
3
PDF
Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension
2024
·
Juzar Ali
, Jasmanda Wu
, et al.
·
Pulmonary Therapy
·
3
PDF
583. Preferences and Attitudes of Healthcare Providers towards Pneumococcal Conjugate Vaccines (PCVs) for Children Ages Two and Under in the United States (US)
2022
·
Salini Mohanty
, Jui-Hua Tsai
, et al.
·
Open Forum Infectious Diseases
·
1
Content Validity of the Hemophilia Device Handling and Preference Assessment Questionnaire - A Cognitive Debrief Study in Patients with Hemophilia and Their Caregivers
2025
·
Niklas Rasmussen
, Sanket Shah
, et al.
·
Patient Preference and Adherence
PDF
A Qualitative Interview Study to Explore the Use of Adverse Event Mitigation Strategies Among Adults Receiving Amikacin Liposome Inhalation Suspension (ALIS) in Real World Settings
2023
·
J. Ali
, J. Wu
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Understanding what matters to metastatic castration-resistant prostate cancer (mCRPC) patients when considering treatment options: A US survey.
2022
·
Daniel J. George
, Ateesha F. Mohamed
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
16
Citation count:
149
H-index:
7
I10-index:
6
Year
Topic
Type
